Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Recently, TÜV SÜD Product Service GmbH an EU Notified Body certified the first IVDR CE certificate in the field of chemiluminescence in China, and its winner is Shenzhen New Industries Biomedical Engineering Co., Ltd.

View this email in Your Browse Official Website Click for more Timetable of CACLP CISCE 2021 will be continuously updated. Read More The 8th China IVD Industry Development Conference The 8th China IVD Industry Development Conference is sche

On December 8, 2020, Beckman Coulter, Inc. and Realcan signed a strategic cooperation agreement in Shanghai and held a cooperation exchange meeting.

Maccura and Hoyotek Bio obtained the CE for their COVID-19 products.

Hann Pang, currently vice president of business operations in China, will take over as the president of Thermo Fisher China.

According to the info. released by NMPA, the certificate of the new type of medical equipment of 2019-nCov nucleic acid reagent kit (CRISPR with immunochromatography method) which was published on Dec. 1st researched by Hangzhou ZC Bio-Sci &

According to CBS News in the United States, due to the new crown epidemic or exposure, a total of about 1,500 Mayo Clinic health system staff are unable to work.

View this email in Your Browse Official Website Click for more COVID-19 Test Reagents In Chinese Export White List According to the list from China Chamber of Commerce, there are 446 enterprises producing COVID-19 test reagent that have obt

On November 25, 2020（Beijing time）, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Innovita Biological ' novel coronavirus Innovita 2019-nCoV Ab Test (Colloidal gold).

The listing wave of Chinese IVD companies should pay more attention to the historical investment opportunities in this market rather than the industry dividends due to public health incidents.